|
| |
| | | 63255 | | 01.10.2013 | | CPS Cito Pharma Services GmbH | | | | | | | | | | | | | 01.05. | | | | 01.05. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Sequase XR 50 mg | Retardtabletten | Delayed release tablets (Quetiapine 50 mg) | N05AH04 | CI | | 02 | Sequase XR 150 mg | Retardtabletten | Delayed release tablets (Quetiapine 150 mg) | N05AH04 | CI | | 03 | Sequase XR 200 mg | Retardtabletten | Delayed release tablets (Quetiapine 200 mg) | N05AH04 | CI | | 04 | Sequase XR 300 mg | Retardtabletten | Delayed release tablets (Quetiapine 300 mg) | N05AH04 | CI | | 05 | Sequase XR 400 mg | Retardtabletten | Delayed release tablets (Quetiapine 400 mg) | N05AH04 | CI |
|
|
|
